These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 28844082

  • 1. Molecular Data and the IPSS-R: How Mutational Burden Can Affect Prognostication in MDS.
    Nazha A, Bejar R.
    Curr Hematol Malig Rep; 2017 Oct; 12(5):461-467. PubMed ID: 28844082
    [Abstract] [Full Text] [Related]

  • 2. Prognostic impact of DTA mutation and co-occurring mutations in patients with myelodysplastic syndrome.
    Wang M, Chen P, Li D, Zhao M.
    Mol Biol Rep; 2024 Sep 15; 51(1):985. PubMed ID: 39278886
    [Abstract] [Full Text] [Related]

  • 3. Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes.
    Thol F, Kade S, Schlarmann C, Löffeld P, Morgan M, Krauter J, Wlodarski MW, Kölking B, Wichmann M, Görlich K, Göhring G, Bug G, Ottmann O, Niemeyer CM, Hofmann WK, Schlegelberger B, Ganser A, Heuser M.
    Blood; 2012 Apr 12; 119(15):3578-84. PubMed ID: 22389253
    [Abstract] [Full Text] [Related]

  • 4. Genetic landscape of recurrent ASXL1, U2AF1, SF3B1, SRSF2, and EZH2 mutations in 304 Chinese patients with myelodysplastic syndromes.
    Wu L, Song L, Xu L, Chang C, Xu F, Wu D, He Q, Su J, Zhou L, Xiao C, Zhang Z, Zhao Y, Chen S, Li X.
    Tumour Biol; 2016 Apr 12; 37(4):4633-40. PubMed ID: 26508027
    [Abstract] [Full Text] [Related]

  • 5. [Features and clinical significance of gene mutations in patients with myelodysplastic syndromes with ring sideroblasts].
    Cai YN, Xu ZF, Li B, Qin TJ, Pan LJ, Qu SQ, Hu NB, Liu D, Huang HJ, Shi ZX, Zhang YD, Xiao ZJ.
    Zhonghua Xue Ye Xue Za Zhi; 2020 May 14; 41(5):379-386. PubMed ID: 32536134
    [Abstract] [Full Text] [Related]

  • 6. Mutations of myelodysplastic syndromes (MDS): An update.
    Ganguly BB, Kadam NN.
    Mutat Res Rev Mutat Res; 2016 May 14; 769():47-62. PubMed ID: 27543316
    [Abstract] [Full Text] [Related]

  • 7. Myelodysplastic syndromes: Contemporary review and how we treat.
    Gangat N, Patnaik MM, Tefferi A.
    Am J Hematol; 2016 Jan 14; 91(1):76-89. PubMed ID: 26769228
    [Abstract] [Full Text] [Related]

  • 8. Validation of a prognostic model and the impact of mutations in patients with lower-risk myelodysplastic syndromes.
    Bejar R, Stevenson KE, Caughey BA, Abdel-Wahab O, Steensma DP, Galili N, Raza A, Kantarjian H, Levine RL, Neuberg D, Garcia-Manero G, Ebert BL.
    J Clin Oncol; 2012 Sep 20; 30(27):3376-82. PubMed ID: 22869879
    [Abstract] [Full Text] [Related]

  • 9. Distinct mutation profile and prognostic relevance in patients with hypoplastic myelodysplastic syndromes (h-MDS).
    Yao CY, Hou HA, Lin TY, Lin CC, Chou WC, Tseng MH, Chiang YC, Liu MC, Liu CW, Kuo YY, Wu SJ, Liao XW, Lin CT, Ko BS, Chen CY, Hsu SC, Li CC, Huang SY, Yao M, Tang JL, Tsay W, Liu CY, Tien HF.
    Oncotarget; 2016 Sep 27; 7(39):63177-63188. PubMed ID: 27527853
    [Abstract] [Full Text] [Related]

  • 10. Implications of molecular genetic diversity in myelodysplastic syndromes.
    Bejar R.
    Curr Opin Hematol; 2017 Mar 27; 24(2):73-78. PubMed ID: 27875374
    [Abstract] [Full Text] [Related]

  • 11. Comprehensive analysis of genetic factors predicting overall survival in Myelodysplastic syndromes.
    Maurya N, Mohanty P, Dhangar S, Panchal P, Jijina F, Mathan SLP, Shanmukhaiah C, Madkaikar M, Vundinti BR.
    Sci Rep; 2022 Apr 08; 12(1):5925. PubMed ID: 35396491
    [Abstract] [Full Text] [Related]

  • 12. Mutation status and burden can improve prognostic prediction of patients with lower-risk myelodysplastic syndromes.
    Jiang L, Luo Y, Zhu S, Wang L, Ma L, Zhang H, Shen C, Yang W, Ren Y, Zhou X, Mei C, Ye L, Xu W, Yang H, Lu C, Jin J, Tong H.
    Cancer Sci; 2020 Feb 08; 111(2):580-591. PubMed ID: 31804030
    [Abstract] [Full Text] [Related]

  • 13. Mutations and prognosis in myelodysplastic syndromes: karyotype-adjusted analysis of targeted sequencing in 300 consecutive cases and development of a genetic risk model.
    Gangat N, Mudireddy M, Lasho TL, Finke CM, Nicolosi M, Szuber N, Patnaik MM, Pardanani A, Hanson CA, Ketterling RP, Tefferi A.
    Am J Hematol; 2018 May 08; 93(5):691-697. PubMed ID: 29417633
    [Abstract] [Full Text] [Related]

  • 14. The prognostic impact of mutations in spliceosomal genes for myelodysplastic syndrome patients without ring sideroblasts.
    Kang MG, Kim HR, Seo BY, Lee JH, Choi SY, Kim SH, Shin JH, Suh SP, Ahn JS, Shin MG.
    BMC Cancer; 2015 Jun 27; 15():484. PubMed ID: 26115659
    [Abstract] [Full Text] [Related]

  • 15. [Analysis of mutations of 14 genes among 87 patients with myelodysplastic syndrome].
    Zhou X, Jin H, Mu Q, Sheng L, Lai B, Zhu H, Ouyang G.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Oct 10; 36(10):953-956. PubMed ID: 31598934
    [Abstract] [Full Text] [Related]

  • 16. The Genetics of Myelodysplastic Syndromes: Clinical Relevance.
    Chiereghin C, Travaglino E, Zampini M, Saba E, Saitta C, Riva E, Bersanelli M, Della Porta MG.
    Genes (Basel); 2021 Jul 27; 12(8):. PubMed ID: 34440317
    [Abstract] [Full Text] [Related]

  • 17. Prognostic models in myelodysplastic syndromes.
    Bejar R.
    Hematology Am Soc Hematol Educ Program; 2013 Jul 27; 2013():504-10. PubMed ID: 24319225
    [Abstract] [Full Text] [Related]

  • 18. Incorporation of mutations in five genes in the revised International Prognostic Scoring System can improve risk stratification in the patients with myelodysplastic syndrome.
    Hou HA, Tsai CH, Lin CC, Chou WC, Kuo YY, Liu CY, Tseng MH, Peng YL, Liu MC, Liu CW, Liao XW, Lin LI, Yao M, Tang JL, Tien HF.
    Blood Cancer J; 2018 Apr 04; 8(4):39. PubMed ID: 29618722
    [Abstract] [Full Text] [Related]

  • 19. Targeted next-generation sequencing in myelodysplastic syndromes and prognostic interaction between mutations and IPSS-R.
    Tefferi A, Lasho TL, Patnaik MM, Saeed L, Mudireddy M, Idossa D, Finke C, Ketterling RP, Pardanani A, Gangat N.
    Am J Hematol; 2017 Dec 04; 92(12):1311-1317. PubMed ID: 28875545
    [Abstract] [Full Text] [Related]

  • 20. Prognostic value of SRSF2 mutations in patients with de novo myelodysplastic syndromes: A meta-analysis.
    Zheng X, Zhan Z, Naren D, Li J, Yan T, Gong Y.
    PLoS One; 2017 Dec 04; 12(9):e0185053. PubMed ID: 28953917
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.